This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Mar 22;378(12):1163-4.

doi: 10.1056/NEJMc1801663.

Adverse Events Associated with Immune Checkpoint Blockade

H Kaan Akturk^{1

2}, Aaron W Michels¹

Affiliations

PMID: 29565519
DOI: 10.1056/NEJMc1801663

Comment

Adverse Events Associated with Immune Checkpoint Blockade

H Kaan Akturk et al. N Engl J Med. 2018.

. 2018 Mar 22;378(12):1163-4.

doi: 10.1056/NEJMc1801663.

Authors

H Kaan Akturk^{1

2}, Aaron W Michels¹

Affiliations

¹ University of Colorado School of Medicine, Aurora, CO
² kaanakturk@yahoo.com

PMID: 29565519
DOI: 10.1056/NEJMc1801663

No abstract available

PubMed Disclaimer

Comment in

Adverse Events Associated with Immune Checkpoint Blockade.
Postow MA, Hellmann MD. Postow MA, et al. N Engl J Med. 2018 Mar 22;378(12):1165. doi: 10.1056/NEJMc1801663. N Engl J Med. 2018. PMID: 29562154 No abstract available.

Comment on

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.
Postow MA, Sidlow R, Hellmann MD. Postow MA, et al. N Engl J Med. 2018 Jan 11;378(2):158-168. doi: 10.1056/NEJMra1703481. N Engl J Med. 2018. PMID: 29320654 Review. No abstract available.

Similar articles

Adverse Events Associated with Immune Checkpoint Blockade.
Jhaveri KD, Perazella MA. Jhaveri KD, et al. N Engl J Med. 2018 Mar 22;378(12):1163. doi: 10.1056/NEJMc1801663. N Engl J Med. 2018. PMID: 29565518 No abstract available.
Immune checkpoint blockade: Which switches to hit and how much?
Matlung HL, Szilagyi K, Kuijpers TW, van Lier RAW, van den Berg TK. Matlung HL, et al. Immunol Lett. 2016 Dec;180:73-74. doi: 10.1016/j.imlet.2016.08.014. Epub 2016 Sep 20. Immunol Lett. 2016. PMID: 27662791 No abstract available.
Myocarditis with Immune Checkpoint Blockade.
Ederhy S, Voisin A-L, Champiat S. Ederhy S, et al. N Engl J Med. 2017 Jan 19;376(3):290-1. doi: 10.1056/NEJMc1615251. N Engl J Med. 2017. PMID: 28102662 No abstract available.
Immune-Checkpoint Blockade Therapy in Lymphoma.
Kuzume A, Chi S, Yamauchi N, Minami Y. Kuzume A, et al. Int J Mol Sci. 2020 Jul 30;21(15):5456. doi: 10.3390/ijms21155456. Int J Mol Sci. 2020. PMID: 32751706 Free PMC article. Review.
PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions.
Xia L, Liu Y, Wang Y. Xia L, et al. Oncologist. 2019 Feb;24(Suppl 1):S31-S41. doi: 10.1634/theoncologist.2019-IO-S1-s05. Oncologist. 2019. PMID: 30819829 Free PMC article. Review.

See all similar articles

Cited by

PD-1 Inhibitor Immune-Related Adverse Events in Patients With Preexisting Endocrine Autoimmunity.
Akturk HK, Alkanani A, Zhao Z, Yu L, Michels AW. Akturk HK, et al. J Clin Endocrinol Metab. 2018 Oct 1;103(10):3589-3592. doi: 10.1210/jc.2018-01430. J Clin Endocrinol Metab. 2018. PMID: 30124874 Free PMC article.
Immunotherapy-Related Cardiotoxicity Re-Emergence in Non-Small Cell Lung Cancer - A Case Report.
Li Y, Hu Y, Yang B, Jin C, Ren H, Wu J, Wang Z, Wei Y, Yang L, Hu Y. Li Y, et al. Onco Targets Ther. 2021 Nov 23;14:5309-5314. doi: 10.2147/OTT.S333242. eCollection 2021. Onco Targets Ther. 2021. PMID: 34848973 Free PMC article.
Diabetic ketoacidosis.
Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Dhatariya KK, et al. Nat Rev Dis Primers. 2020 May 14;6(1):40. doi: 10.1038/s41572-020-0165-1. Nat Rev Dis Primers. 2020. PMID: 32409703 Review.
PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy.
Liu J, Chen Z, Li Y, Zhao W, Wu J, Zhang Z. Liu J, et al. Front Pharmacol. 2021 Sep 1;12:731798. doi: 10.3389/fphar.2021.731798. eCollection 2021. Front Pharmacol. 2021. PMID: 34539412 Free PMC article. Review.
Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance.
Couey MA, Bell RB, Patel AA, Romba MC, Crittenden MR, Curti BD, Urba WJ, Leidner RS. Couey MA, et al. J Immunother Cancer. 2019 Jul 3;7(1):165. doi: 10.1186/s40425-019-0645-6. J Immunother Cancer. 2019. PMID: 31269983 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations